2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on Advanced Bladder Cancer: Can We Consider Avelumab 1L Maintenance a New SoC?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Manojkumar Bupathi
By 2020 ASCO Virtual Direct™ Highlights FEATURING Manojkumar Bupathi
48 views
August 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
GU
08:56
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Advanced Prostate Cancer: Is Relugolix Bette…

Feat. B. Somer
13:12
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on PSMA in Prostate Cancer: How Useful Is 18F-DCFP…

Feat. B. Somer
11:01
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on CRPC: Apalutamide vs. Enzalutamide vs. Daroluta…

Feat. B. Somer
11:09
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Bladder Cancer: Can We Consider Aveluma…

Feat. M. Bupathi
12:28
2020 ASCO Virtual Direct™ Highlights

2020 ASCO mRCC Highlights: Does the Updated KEYNOTE-426 Analysis Sup…

Feat. M. Bupathi
08:36
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Bladder Cancer: Does Adjuvant Atezolizumab Impro…

Feat. M. Bupathi